搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Arabidopsis thaliana Flap endonuclease GEN-like 2 (GEN2), partial CSB-YP878680DOA
CSB-EP878680DOA
CSB-BP878680DOA
CSB-MP878680DOA
CSB-EP878680DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable RNA polymerase II transcription factor B subunit 1-3 (TFB1-3), partial CSB-YP878681DOA
CSB-EP878681DOA
CSB-BP878681DOA
CSB-MP878681DOA
CSB-EP878681DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Telomere repeat-binding protein 6 (TRP6) CSB-YP878682DOA
CSB-EP878682DOA
CSB-BP878682DOA
CSB-MP878682DOA
CSB-EP878682DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Beclin-1-like protein (At3g61710), partial CSB-YP878683DOA
CSB-EP878683DOA
CSB-BP878683DOA
CSB-MP878683DOA
CSB-EP878683DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Ataxin-3 homolog (At3g54130) CSB-YP878684DOA
CSB-EP878684DOA
CSB-BP878684DOA
CSB-MP878684DOA
CSB-EP878684DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana 60S ribosomal protein L23a-2 (RPL23AB) CSB-YP878685DOA
CSB-EP878685DOA
CSB-BP878685DOA
CSB-MP878685DOA
CSB-EP878685DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable cadmium/zinc-transporting ATPase HMA1, chloroplastic (HMA1), partial CSB-YP878686DOA
CSB-EP878686DOA
CSB-BP878686DOA
CSB-MP878686DOA
CSB-EP878686DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spinacia oleracea NAD (P)H-quinone oxidoreductase chain 4, chloroplastic (ndhD), partial CSB-YP878687FKI
CSB-EP878687FKI
CSB-BP878687FKI
CSB-MP878687FKI
CSB-EP878687FKI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spinacia oleracea Chloroplast envelope membrane protein (cemA), partial CSB-YP878688FKI1
CSB-EP878688FKI1
CSB-BP878688FKI1
CSB-MP878688FKI1
CSB-EP878688FKI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spinacia oleracea Maturase K (matK), partial CSB-YP878689FKI
CSB-EP878689FKI
CSB-BP878689FKI
CSB-MP878689FKI
CSB-EP878689FKI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Meiotic recombination protein SPO11-2 (SPO11-2) CSB-YP878690DOA
CSB-EP878690DOA
CSB-BP878690DOA
CSB-MP878690DOA
CSB-EP878690DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Monoclea forsteri 30S ribosomal protein S4, chloroplastic (rps4) CSB-YP878691MMAA
CSB-EP878691MMAA
CSB-BP878691MMAA
CSB-MP878691MMAA
CSB-EP878691MMAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Solanum tuberosum Phosphoglucomutase, cytoplasmic (PGM1), partial CSB-YP878692FIG
CSB-EP878692FIG
CSB-BP878692FIG
CSB-MP878692FIG
CSB-EP878692FIG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesembryanthemum crystallinum 30S ribosomal protein S10, chloroplastic (RPS10) CSB-YP878693MRC
CSB-EP878693MRC
CSB-BP878693MRC
CSB-MP878693MRC
CSB-EP878693MRC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Perilla frutescens 60S ribosomal protein L31 (RPL31) CSB-YP878694ETR
CSB-EP878694ETR
CSB-BP878694ETR
CSB-MP878694ETR
CSB-EP878694ETR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Polygalacturonase inhibitor 2 (PGIP2) CSB-YP878695DOA
CSB-BP878695DOA
CSB-MP878695DOA
CSB-EP878695DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Euphorbia esula 60S ribosomal protein L10 (RPL10) CSB-YP878696EIG
CSB-EP878696EIG
CSB-BP878696EIG
CSB-MP878696EIG
CSB-EP878696EIG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrus communis Non-specific lipid-transfer protein CSB-YP878697FIA
CSB-EP878697FIA
CSB-BP878697FIA
CSB-MP878697FIA
CSB-EP878697FIA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana IAA-alanine resistance protein 1 (IAR1), partial CSB-YP878698DOA1
CSB-EP878698DOA1
CSB-BP878698DOA1
CSB-MP878698DOA1
CSB-EP878698DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Taxus cuspidata Taxadien-5-alpha-ol O-acetyltransferase (TAT) CSB-YP878699TCAC
CSB-EP878699TCAC
CSB-BP878699TCAC
CSB-MP878699TCAC
CSB-EP878699TCAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>